Banque Pictet & Cie’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $675K | Hold |
1,282
| – | – | ﹤0.01% | 255 |
|
|
2026
Q1 | $720K | Sell |
1,282
-918
| -42% | -$589K | 0.01% | 292 |
|
|
2025
Q4 | $1.49M | Hold |
2,200
| – | – | 0.01% | 236 |
|
|
2025
Q3 | $1.41M | Hold |
2,200
| – | – | 0.01% | 246 |
|
|
2025
Q2 | $1.18M | Sell |
2,200
-380
| -15% | -$182K | 0.01% | 242 |
|
|
2025
Q1 | $1.08M | Sell |
2,580
-458
| -15% | -$199K | 0.01% | 247 |
|
|
2024
Q4 | $1.26M | Sell |
3,038
-535
| -15% | -$235K | 0.01% | 235 |
|
|
2024
Q3 | $1.81M | Buy |
3,573
+880
| +33% | +$428K | 0.01% | 199 |
|
|
2024
Q2 | $1.31M | Hold |
2,693
| – | – | 0.01% | 212 |
|
|
2024
Q1 | $1.45M | Sell |
2,693
-570
| -17% | -$312K | 0.01% | 213 |
|
|
2023
Q4 | $1.81M | Sell |
3,263
-2,737
| -46% | -$1.28M | 0.02% | 206 |
|
|
2023
Q3 | $2.62M | Buy |
6,000
+704
| +13% | +$351K | 0.03% | 186 |
|
|
2023
Q2 | $2.66M | Buy |
5,296
+458
| +9% | +$219K | 0.02% | 217 |
|
|
2023
Q1 | $2.42M | Buy |
4,838
+350
| +8% | +$167K | 0.02% | 247 |
|
|
2022
Q4 | $1.83M | Buy |
4,488
+483
| +12% | +$187K | 0.02% | 302 |
|
|
2022
Q3 | $1.3M | Sell |
4,005
-34,742
| -90% | -$12.8M | 0.01% | 356 |
|
|
2022
Q2 | $13.6K | Buy |
38,747
+4,672
| +14% | +$1.91M | 0.13% | 85 |
|
|
2022
Q1 | $18.6M | Sell |
34,075
-842
| -2% | -$443K | 0.14% | 82 |
|
|
2021
Q4 | $23M | Sell |
34,917
-4,190
| -11% | -$2.63M | 0.17% | 72 |
|
|
2021
Q3 | $24.3M | Sell |
39,107
-1,144
| -3% | -$769K | 0.25% | 59 |
|
|
2021
Q2 | $25.4M | Sell |
40,251
-6,810
| -14% | -$3.76M | 0.28% | 53 |
|
|
2021
Q1 | $23M | Buy |
47,061
+269
| +0.6% | +$135K | 0.3% | 49 |
|
|
2020
Q4 | $23.4M | Buy |
46,792
+2,015
| +5% | +$902K | 0.32% | 48 |
|
|
2020
Q3 | $17.6M | Sell |
44,777
-4,670
| -9% | -$1.73M | 0.27% | 52 |
|
|
2020
Q2 | $16.3M | Sell |
49,447
-1,670
| -3% | -$484K | 0.27% | 49 |
|
|
2020
Q1 | $12.4M | Buy |
51,117
+10,606
| +26% | +$2.77M | 0.25% | 51 |
|
|
2019
Q4 | $10.6M | Hold |
40,511
| – | – | 0.18% | 83 |
|
|
2019
Q3 | $11M | Sell |
40,511
-2,785
| -6% | -$775K | 0.21% | 71 |
|
|
2019
Q2 | $11.9M | Sell |
43,296
-2,539
| -6% | -$626K | 0.22% | 62 |
|
|
2019
Q1 | $10.2M | Buy |
45,835
+6,220
| +16% | +$1.28M | 0.2% | 73 |
|
|
2018
Q4 | $7.37M | Buy |
39,615
+38,380
| +3,108% | +$7.87M | 0.15% | 99 |
|
|
2018
Q3 | $308K | Hold |
1,235
| – | – | 0.01% | 323 |
|
|
2018
Q2 | $269K | Hold |
1,235
| – | – | 0.01% | 324 |
|
|
2018
Q1 | $236K | Buy |
+1,235
| New | +$228K | 0.01% | 342 |
|
Other funds holding IDXX
MBI
CGI
CAM
RG
SIM
BPCE
MJRIC
RP
Banque Pictet & Cie's IDXX Position: Q2 2026 in Review
Banque Pictet & Cie held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1,282 shares worth $675K. The position accounts for ﹤0.01% of the portfolio, ranked #255.
Banque Pictet & Cie first reported a position in IDXX in Q1 2018 and has held it in 34 quarters since. The position peaked at $25.4M in Q2 2021. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Banque Pictet & Cie held 1,282 shares of Idexx Laboratories worth $675K as of Q2 2026.
- Banque Pictet & Cie left its Idexx Laboratories share count unchanged in Q2 2026.
- Idexx Laboratories made up ﹤0.01% of Banque Pictet & Cie's portfolio in Q2 2026, its #255 holding.
- Banque Pictet & Cie first reported a position in Idexx Laboratories in Q1 2018 and has held it in 34 quarters since.
- Banque Pictet & Cie's Idexx Laboratories position peaked at $25.4M in Q2 2021.
- 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.